Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Aurinia Pharmaceuticals Inc. market cap for the quarter ending 2026-08-05 was $2.02B, a 71.63% increase year-over-year.
Aurinia Pharmaceuticals Inc. market cap for the quarter ending 2026-06-30 was $2.25B, a 100.42% increase year-over-year.
Aurinia Pharmaceuticals Inc. market cap for the quarter ending 2026-05-06 was $2.09B, a 90.73% increase year-over-year.
Aurinia Pharmaceuticals Inc. market cap for the quarter ending 2026-03-31 was $1.94B, a 75.23% increase year-over-year.
Aurinia Pharmaceuticals Inc. market cap for fiscal 2026 was $2.02B.
Aurinia Pharmaceuticals Inc. market cap for fiscal 2025 was $2.11B, a 66.72% increase from fiscal 2024.
Aurinia Pharmaceuticals Inc. market cap for fiscal 2024 was $1.27B, a 2.16% decline from fiscal 2023.
Aurinia Pharmaceuticals Inc. market cap for fiscal 2023 was $1.29B, a 110.39% increase from fiscal 2022.